Since 1987, Boston Analytical has been performing dissolution testing, the measure of a drug’s rate of release from its dosage form. During that time we have created hundreds of custom methods and USP <711> methods. Our expertise is unsurpassed in this area with one of the widest variety of apparatuses to include multiple Dissolution Apparatus IV instruments, as well as the use of HPLC systems. We are committed to providing quick and accurate results for your drug development, quality control, comparator studies and for your stability studies to determine the effects of time, temperature and humidity.

Boston Analytical is willing to work with you to provide a custom-designed method for HPLC analysis in dissolution analysis, or you may choose from those we already have proven. All of our methods are in compliance with USP and ICH guidelines, using either your protocols or our own. Boston Analytical’s methods are written in an easy to understand, step by step format, to simplify method transfer. And, if you would like some assistance to do the work in-house, we also provide dissolution analysis consulting. We will work with you to ensure the best fit for your dissolution analysis needs.

Pharmaceutical dissolution testing benefits drug manufacturers because it provides them with valuable insights into how the dosage form impacts its efficacy. The results this process delivers are crucial for understanding the bioavailability and effectiveness of a drug in its current form.

This enables pharmaceutical companies to make more-informed decisions about how their products will eventually reach patients. As a leader in providing these services, Boston Analytical has proven to be a valuable partner to companies all over the world.

If you would like to learn more about our full capabilities and how they can serve your operations, get in touch with one of our representatives today.